Active Ingredient: RILUZOLE
Proprietary Name: RILUZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204430
Product Number: 001
Approval Date: Oct 16, 2018
Applicant Holder Full Name: DAITO PHARMACEUTICALS CO LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
